Bayer Faces More Weedkiller Woes as U.S. Court Bans Dicamba
- Appeals panel faults EPA for understating weed killer’s risks
- BASF could lose $100 million, and Bayer even more: analyst
This article is for subscribers only.
Bayer AG is blocked from selling its controversial dicamba-based herbicide in the U.S. after an appeals court rejected a federal regulator’s permit for the product, compounding the German company’s weed-killer woes.
The three-judge panel concluded the Environmental Protection Agency had “failed entirely” to acknowledge some risks dicamba poses and that the agency violated federal regulations when it extended its approval of registration for the herbicide for another two years in October 2018.